Corcept Therapeutics director James N. Wilson reports sale of $1.15 million in common shares
CORT•Corcept Therapeutics director James N. Wilson sold 10,000 common shares on Oct. 15, 2026, for about $1.15 million. The Wilson family trust held 1,054,543 shares after the sales, while two grantor retained annuity trusts held another 400,000 indirectly.
1. Share sale details
Wilson sold 10,000 common shares on Oct. 15, 2026: 6,654 shares at $114.4751, 3,046 at $115.3895 and 300 at $116.2967. After the sales, the James N. Wilson and Pamela D. Wilson Trust held 1,054,543 common shares, and two grantor retained annuity trusts held another 400,000 shares indirectly.
